Initial testing of the antiretroviral medication complexity index

Journal of the Association of Nurses in AIDS Care

Volumn 17, Issue 1, 2006, Pages 26-36

  DiIorio, Colleen ^a   McDonnell, Marcia ^b   McCarty, Frances ^a   Yeager, Katherine ^a  

^a EMORY UNIVERSITY   (United States)

^b EMORY UNIVERSITY   (United States)

Author keywords

Antiretroviral medications; Instrument development; Medication complexity

Indexed keywords

EID: 33644767064     PISSN: 10553290     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jana.2005.11.003     Document Type: Article

References (16)

1. Chesney, M., Morin, M., Sherr, L. (2000). Adherence to HIV combination therapy. Social Science and Medicine, 50, 1599-1605.
2. Chesney, M. A., Ickovics, J. R., Chambers, D. B., Gifford, A. L., Neidig, J., Zwickl, B., et al. (2000). Self-reported adherence to antiretroviral medications among participants in HIV clinical trials: The AACTG adherence instruments. Patient Care Committee & Adherence Working Group of the Outcomes Committee of the Adult AIDS Clinical Trials Group (AACTG). AIDS Care, 12(3), 255-266.
3. Conn, V. S., Taylor, S. G., & Kelley, S. (1991). Medication regimen complexity and adherence among older adults. Image, 23(4), 231-235.
4. Dilorio, C., Yeager, K., Shafer, P. O., Letz, R., Henry, T., Schomer, D. L., et al. (2003). The epilepsy medication and treatment complexity index: Reliability and validity testing. Journal of Neuroscience Nursing, 35(3), 155-162.
5. Eldred, L. J., Wu, A. W., Chaisson, R. E., Moore, R. D. (1998). Adherence to antiretroviral and pneumocystis prophylaxis in HIV disease. Journal of Acquired Immune Deficiency Syndromes & Human Retrovirology, 18(2), 117-125.
6. Hinkin, C. H., Castellon, S. A., Durvasula, R. S., Hardy, D. J., Lam, M. N., Mason, K. I., et al. (2002). Medication adherence among HIV+ adults: Effects of cognitive dysfunction and regimen complexity. Neurology, 59(12), 1944-1950.
7. Ickovics, J. R., Carneron, A., Zackin, R., Bassett, R., Chesney, M., Johnson, V. A., et al. (2002). Consequences and determinants of adherence to antiretroviral medication: results from Adult AIDS Clinical Trials Group protocol 370. Antiviral Therapy, 7(3), 185-193.
8. Kelley S. O. (1988). Measurement of the complexity of medication regimens of the elderly. Unpublished master's thesis, University of Missouri, Columbia.
9. McDonnell, M., Turner, J., & Weaver, M. T. (2001). Antecedents of adherence to antituberculosis therapy. Public Health Nursing, 18(6), 392-400.
10. Mehta, S., Moore, R. D., & Graham, N. M. (1997). Potential factors affecting adherence with HIV therapy. AIDS, 11(14), 1665-1670.
11. Mikulecky, D. C. (2001). The emergence of complexity: Science coming of age or science growing old? Computers and Chemistry, 25, 341-348.
12. Miller N. H. (1997). Compliance with treatment regimens in chronic asymptomatic diseases. American Journal of Medicine, 102(2A), 43-49.
13. Paterson, D. L., Swindells, S., Mohr, J., Brester, M., Vergis, E. N., Squier, C., et al. (2000). Adherence to protease inhibitor therapy and outcomes in patients with HIV infection. Annals of Internal Medicine, 133(1), 21-30.
14. Stone, V. E., Hogan, J. W., Schuman, P., Rompalo, A. M., Howard, A. A., Korkontzelou, C., et al. (2001). Antiretroviral regimen complexity, self-reported adherence, and HIV patients' understanding of their regimens: Survey of women in the HER study. Journal of Acquired Immune Deficiency Syndromes, 28(2), 124-131.
15. Stone, V. E., Jordan, J., Tolson, J., Miller, R., Pilon, T. (2004). Perspectives on adherence and simplicity for HIV-infected patients on antiretroviral therapy: Self report of relative importance of multiple attributes of highly active antiretroviral therapy regimes in predicting adherence. Journal of Acquired Immune Deficiency Syndromes, 36(3), 808-816.
16. U.S. Department of Health and Human Services. (2004). A guideline for the use of ARV in HIV-1 infected adults and adolescent. HIV/AIDS Treatment Information Service Online.Retrieved October 29, 2004, from http://aidsinfo.nih. gov/guidelines